Kilo Health, formerly known as Kilo Health, is evolving into a "high-velocity venture studio", co-founding startups and investing in early-stage companies across health, longevity, beauty, and travel.

Strategy and Vision

Žygimantas Surintas, CEO of Kilo, explains that the change reflects a broader strategy: Kilo intends to start and invest in companies that can develop quickly. The internal ecosystem, Kiloverse, provides founders with access to marketing expertise, technology tools, and global partnerships.

Kilo invests in startups, supporting them from the MVP stage to scale-up, with tickets ranging from €50,000 to €1 million, and follow-on funding up to €10 million. To date, it has invested over €10 million in external startups and almost twice that in internal R&D.

Market Focus and AI

Kilo targets specific markets, leveraging customer data to offer targeted products. The company plans to invest up to €20 million in AI development over the next three years, with the goal of reaching $1 billion in consolidated annual revenue. However, the adoption of AI will be gradual, to avoid negative impacts on sales.

Successes and Challenges

Surintas considers Kilo's independence, achieved without external funding, its greatest success. The biggest challenge was managing the too-rapid growth, which made it difficult to quickly control and adjust the business.

For founders, the advice is to accept help and not excessively protect their initial equity stake. Kilo seeks solid partners, capable of working hard, and emphasizes that constant commitment is fundamental, even in the age of AI.